InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain
InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
HAG | Ann: NAME: HAG: HAG: Name and Ticker Code Change | 18/03/13 | 0 | 443 | |||
|
|||||||
HAG | Ann: NAME: HAG: Change of name and results of Ten | 18/03/13 | 0 | 498 | |||
|
|||||||
HAG | Ann: NTA: HAG: HAG - Net Asset Value as at 14 Mar | 18/03/13 | 0 | 375 | |||
|
|||||||
HAG | Ann: NTA: HAG: HAG-Net Asset Values as at 13 Marc | 15/03/13 | 0 | 400 | |||
|
|||||||
HAG | Ann: NTA: HAG: HAG - Net Asset Value as at 12 Mar | 14/03/13 | 0 | 500 | |||
|
|||||||
HAG | Ann: NTA: HAG: HAG - Net Asset Value as at 11 Mar | 13/03/13 | 0 | 282 | |||
|
|||||||
HAG | Ann: NTA: HAG: HAG - Net Asset Value as at 8 Marc | 12/03/13 | 0 | 295 | |||
|
|||||||
HAG | Ann: FLLYR: HAG: HAG - Final Results | 12/03/13 | 0 | 336 | |||
|
See All Discussions